Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade neuroendocrine lung and prostate cancers

Journal:

Proceedings of the National Academy of Sciences of the United States of America

Published:

2026-02-02

DOI:

10.1073/pnas.2505785123

Affiliations:

7

Authors:

19

Go to article

Institutions	Authors	Share
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)	11.833333 11.833333	0.62
Tri-Institutional Therapeutics Discovery Institute, United States of America (USA)	6.000000	0.32
Weill Cornell Medicine, United States of America (USA)	1.166667	0.06

Interested in Oncology and Carcinogenesis?